Nova Biomedical Recalls StatStrip Glucose Meters
The FDA identified a software issue in Gen 2.0 hospital glucose monitoring systems that risks assigning data to incorrect patients.
Updated on Oct. 20, 2026 in Diabetes
Nova Biomedical initiated a recall for its StatStrip Glucose Hospital Meter Gen 2.0 systems after discovering barcode scanning may retain prior patient information. The FDA has classified the recall as the most serious type due to the risk of assigning glucose results to the wrong medical record.
Why it matters
The software defect poses a significant clinical risk, as incorrect patient data can lead to dangerous medical decisions for hospital patients. Ensuring the accuracy of electronic health records is critical for patient safety in inpatient settings.
The recall involves one reported serious injury and zero deaths linked to the StatStrip Glucose Hospital Monitoring System. The company currently advises users to verify patient IDs manually while awaiting a software update.
The players
Nova Biomedical
Nova Biomedical is a manufacturer of medical diagnostic equipment and hospital monitoring systems.
FDA
The FDA is the federal agency responsible for protecting public health by ensuring the safety and efficacy of medical devices.
The details
The software issue allows a device to potentially display information from a previous patient after a barcode scan is completed. To mitigate risks, the company instructs users to configure devices for automatic logouts and to manually verify displayed patient IDs before accepting results into a record.
Timeline
July 31, 2026: Nova Biomedical sent the initial recall letter to customers.
October 5, 2026: The company issued an updated letter and reported one injury.
November 2026: Nova Biomedical plans to release a software update for the devices.
The Big Picture
The FDA Medical Device Recall classification system establishes the regulatory standard for addressing software-related risks in clinical equipment. This recall marks an intervention within that framework to prevent potential errors in hospital electronic health record systems.
Hospital staff should ensure devices are configured for automatic logouts after every test to minimize the risk of data carryover. Providers must manually verify that the patient ID on the meter screen matches the patient currently undergoing testing.
The takeaway
Clinical teams must remain vigilant with barcode-reliant equipment by confirming digital displays match physical patient identification. Manual verification protocols serve as a vital final safeguard against software errors that could otherwise compromise electronic medical records.
What happens next
Nova Biomedical is scheduled to release a software update for the affected StatStrip Glucose Hospital Meter Gen 2.0 units in November 2026.
Further reading
For more information on medical management, visit the United States Diabetes section.
Source note: This article includes information reported by U.S. Food and Drug Administration.
